Abstract Search

ea0049oc14.1 | Thyroid Cancer | ECE2017

Anti-Mullerian hormone (AMH) in pre-menopausal females after ablative radioiodine (RAI) treatment for differentiated thyroid cancer (DTC): single-center study

Mittica Miranda , Comite Paola , Campana Claudia , Gay Stefano , Mussap Michele , Giusti Massimo

Background: It is generally reported that female fertility is not affected by high-dose RAI treatment. AMH has been considered a reliable and accurate index of ovarian reserve. There are few data on AMH values in thyroid diseases. Recently, in DTC women who had undergone RAI ablation treatment, Acibucu et al. (2016) reported low AMH levels without significant impairment of fertility.Aim: The aim of this single-center study was to evaluate AMH le...

0 shares

ea0056p1046 | Thyroid (non-cancer) | ECE2018

Active surveillance of indeterminate thyroid nodules beyond cytological diagnosis, ultrasound evaluation and molecular analysis

Santamorena Graziana , Gay Stefano , Mittica Miranda , Monti Eleonora , Massa Barbara , Giusti Massimo

Most thyroid nodules are benign after fine needle aspiration biopsy (FNAB). Nevertheless approximately 1025% of nodules are classified in indeterminate classes. Literature reports different risks of malignancy in Thy 3 Thy 4 nodules. In our center malignancy was observed in 26% of Thy 3a nodules and 14% of the Thy 3f nodules (Giusti et al. 2017) while it was >75% in Thy 4 nodules. Strategies for nodules stratification according to risk are now needed ...

0 shares

Endocrine Abstracts

Anti-Mullerian hormone (AMH) in pre-menopausal females after ablative radioiodine (RAI) treatment for differentiated thyroid cancer (DTC): single-center study

Active surveillance of indeterminate thyroid nodules beyond cytological diagnosis, ultrasound evaluation and molecular analysis

BiosciAbstracts